I won't be surprised if IHL will be $1B Au equivalent plus upon a US listing. (and that would be low by US standards IMO) Their markets are a serious step ahead of Au and they are used to much higher valuations for CBD/Psychedelics. (by a massive margin) With the great progress so far across clinical trials, there is little that compares (none that have both CBD/Psch) to IHL in a focused portfolio.
Gordonsgecko posted a great list of Psych stocks. I don't think the Au market has factored this in - you can bet the US will. (well we will eventually get there here in Au...... when the penny drops, maybe after the stock takes off and everyone follows)
Last week's Ann to me was a considerable de-risk and I would imagine very favourable from a US market perspective.
IHL Price at posting:
25.0¢ Sentiment: Buy Disclosure: Held
